New Therapies for Lowering Triglyceride-Rich Lipoproteins
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference66 articles.
1. Genetics of triglyceride-rich lipoproteins guide identification of pharmacotherapy for cardiovascular risk reduction;Shaik;Cardiovasc Drugs Ther,2021
2. 2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee;Virani;J Am Coll Cardiol,2021
3. Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease;Chait;Diabetes,2020
4. Triglyceride-rich lipoprotein remnants and cardiovascular disease;Duran;Clin Chem,2021
5. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM;Langlois;Clin Chem Lab Med,2020
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia;New England Journal of Medicine;2024-09-12
2. Further Reading;Cholesterol, Lipoproteins, and Cardiovascular Health;2024-09-06
3. Dietary isoflavone intake is inversely associated with remnant cholesterol in US adults: A cross-sectional study;Heart & Lung;2024-09
4. Association of remnant cholesterol with sarcopenia in Korean adults: a nationwide population-based study using data from the KNHANES;Frontiers in Endocrinology;2024-08-23
5. Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease;International Journal of Molecular Sciences;2024-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3